Crcm LP Acquires New Stake in Grail, Inc. (NASDAQ:GRAL)

Crcm LP acquired a new stake in shares of Grail, Inc. (NASDAQ:GRAL) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 3,644,855 shares of the company’s stock, valued at approximately $65,061,000. Grail accounts for 26.5% of Crcm LP’s portfolio, making the stock its 2nd biggest holding. Crcm LP owned 10.85% of Grail as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. FNY Investment Advisers LLC bought a new stake in Grail during the 4th quarter valued at $26,000. Lindbrook Capital LLC bought a new stake in Grail during the 4th quarter valued at $28,000. New York State Common Retirement Fund bought a new stake in Grail during the 4th quarter valued at $59,000. Wilmington Savings Fund Society FSB bought a new stake in Grail during the 4th quarter valued at $64,000. Finally, PNC Financial Services Group Inc. bought a new stake in Grail during the 4th quarter valued at $86,000.

Grail Price Performance

GRAL opened at $32.09 on Tuesday. Grail, Inc. has a 12 month low of $12.33 and a 12 month high of $63.99. The stock has a fifty day moving average price of $30.91 and a 200-day moving average price of $20.98.

Grail (NASDAQ:GRAL) last announced its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, topping the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million for the quarter, compared to analysts’ expectations of $35.33 million. Analysts expect that Grail, Inc. will post -15.15 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts have recently commented on GRAL shares. Morgan Stanley started coverage on Grail in a research report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price target for the company. Wolfe Research started coverage on Grail in a research report on Friday, November 15th. They issued a “peer perform” rating for the company.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.